Advance your oncology research with our discovery services

When your oncology research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools and experience to help move life-changing drug candidates through preclinical development and beyond quickly and effectively. Our discovery oncology solutions consist of in vitro assessments, in vivo pharmacology services, in vivo imaging technologies and focal radiation capabilities to support your oncology research programs. We excel in a variety of therapeutic approaches including small molecules, antibody therapeutics, CAR T/TCR, NK-CAR and other adoptive cell therapies, nucleic acids, nanoparticles, oncolytic viruses, protein/peptide therapeutics, radionuclides, stem cells, microbiome, chemotherapies and radiation therapy. Human and syngeneic tumor models within our offerings provide decision-driving data, helping you advance the next research breakthrough for your drug candidate.